Bicara
Back to full portfolio
Bicara Therapeutics is a clinical-stage biopharmaceutical company. It develops bifunctional antibodies for solid tumors, with a lead candidate that pairs an EGFR-directed antibody with a TGF-β ligand trap, built around engaging the tumor cell and its surrounding microenvironment in a single molecule. That dual engagement yields candidates designed to reach further into tumors and sustain responses alongside immune checkpoint therapy.
FOUNDER(S)
Claire Mazumdar
LEADERSHIP
Claire Mazumdar
Bicara Therapeutics is a clinical-stage biopharmaceutical company. It develops bifunctional antibodies for solid tumors, with a lead candidate that pairs an EGFR-directed antibody with a TGF-β ligand trap, built around engaging the tumor cell and its surrounding microenvironment in a single molecule. That dual engagement yields candidates designed to reach further into tumors and sustain responses alongside immune checkpoint therapy.